Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06041529 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06041529 · ClinicalTrials.gov record · last posted 2026-02-13

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

StatusActive, Not Recruiting
PhasePhase 4
Started2023-10-18
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 13, 2026 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
This study is to compare the efficacy and safety of Telmisartan, Amlodipine, and Chlorthalidone Fixed-Dose Combination and Telmisartan, Amlodipine, and Hydrochlorothiazide in Elderly Patients with Essential Hypertension Uncontrolled by Telmisartan and Amlodipine Combinations

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2023-09-11; most recent amendment 2026-02-12. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2026-02-12
Status change Recruiting→Active, Not Recruitingv2
2024-11-13
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT06041529
Lead Sponsor Yuhan Corporation
Conditions Essential Hypertension
Enrollment 198 participants
Start Date 2023-10-18
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-02-13